Strategies for the labeling of halogen-substituted peroxisome proliferator-activated receptor γ ligands: Potential positron emission tomography and single photon emission computed tomography imaging agents

Bioconjugate Chemistry

Volumn 18, Issue 2, 2007, Pages 514-523

  Lee, Byung Chul ^a   Lee, Kyo Chul ^b   Lee, Hsiaoju ^c   Mach, Robert H ^c   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; AROMATIZATION; CHELATION; CYTOLOGY; FLUORINATION; FLUORINE; FLUORINE COMPOUNDS; HALOGENATION; IODINE; IONS; LIGANDS; PARTICLE BEAMS; POSITRON EMISSION TOMOGRAPHY; SULFUR COMPOUNDS;

ADIPOCYTE DIFFERENTIATION; ANTI-TUMORS; FLUORIDE ION; HIGH AFFINITY; IMAGING AGENT; LABELINGS; LIPID METABOLISMS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; SYNTHESISED; TOMOGRAPHY IMAGING;

AROMATIC COMPOUNDS;

(2 BENZOYLPHENYLAMINO) 3 [4 [2 [2 (4 BROMOPHENYL) 5 METHYLOXAZOL 4 YL]ETHOXY]PHENYL]PROPIONIC ACID; (2 BENZOYLPHENYLAMINO) 3 [4 [2 [2 (4 FLUOROPHENYL) 5 METHYLOXAZOL 4 YL]ETHOXY]PHENYL]PROPIONIC ACID; (2 BENZOYLPHENYLAMINO) 3 [4 [2 [2 (4 IODOPHENYL) 5 METHYLOXAZOL 4 YL]ETHOXY]PHENYL]PROPIONIC ACID; BROMINE; FLUORINE; IODINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; DESTANNYLATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORINATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REACTION TIME; RECEPTOR AFFINITY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ANALYSIS;

EID: 33947704129     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc060191g     Document Type: Article

References (42)

1. Issemann, I., and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 347, 645-650.
2. Greene, M. E., Blumberg, B., McBride, O. W., Yi, H. F., Kronquist, K., Kwan, K., Hsieh, L., Greene, G., and Nimer, S. D. (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Express. 4, 281-289.
3. Schmidt, A., Endo, N., Rutledge, S. J., Vogel, R., Shinar, D., and Rodan, G. A. (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6, 1634-1641.
4. Lemberger, T., Desvergne, B., and Wahli, W. (1996) Peroxisome proliferator-activated receptors: A nuclear recepor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335-363.
5. Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S. R., Beck, K. D., Moore, L. B., Kliewer, S. A., and Lehmann, J. M. (1996) The structure-activity relationship between peroxisom proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665-668.
6. Brun, R. P., Kim, J. B., Hu, E., and Spiegelman, B. M. (1997) Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr. Opin. Lipidol. 8, 212-218.
7. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differntiation. Cell 83, 813-819.
8. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 91, 7355-7359.
9. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994) mPPAR γ2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
10. Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X. P., Eng, C., Spiegelman, B. M., and Kantoff, P. W. (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 10990-10995.
11. Muller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C. D., Singer, S., and Spiegelman, B. M. (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1, 465-470.
12. Demetri, G. D., Fletcher, C. D. M., Mueller, E., Sarraf, F., Naujoks, R., Campbell, N., Spiegelman, B. M., and Singer, S. (1999) Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc. Natl. Acad. Sci. U.S.A. 96, 3951-3956.
13. Tontonoz, P., Singer, S., Froman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 237-241.
14. Burstein, H. J., Demetri, G. D., Muller, E., Sarraf, P., Spiegelman, B. M., and Winer, E. P. (2003) Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer: a phase II study. Breast Cancer Res. Treat. 79, 391-397.
15. Wang, Xin., Southard, R. C., and Kilgore, M. W. (2004) The increased expression of peroxisome proliferator-activatated receptor-γ 1 in human breast cancer is mediated by selective promoter usage. Cancer Res. 64, 5592-5596.
16. Berger, J. P., Akiyama, T. E., and Meinke, P. T. (2005) PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26, 244-251.
17. Kim, S-H., Jonson, S. D., Welch, M. J., and Katzenellenbogen, J. A. (2001) Fluorine-Substituted ligands for the peroxisome proliferator-activated receptor gamma (PPARγ): Potential imaging agents for metastatic tumors. Bioconjugate Chem. 12, 439-450.
18. Gray, S. L., Dalla Nora, E., and Vidal-Puig, A. J. (2005) Mouse models of PPAR-gamma deficiency: dissecting PPAR-gamma's role in metabolic homoeostasis. Biochem. Soc. Trans. 33, 1053-1058.
19. Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, W. W., Jr., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., Kliewer, S. A., Lake, D. H., Leesnitzer, L. M., Lehmann, J. M., Lenhard, J. M., Orband-Miller, L. A., Miller, J. F., Mook, R. A., Jr., Noble, S. A., Oliver, W., Jr., Parks, D. J., Plunket, K. D., Szewczyk, J. R., and Willson, T. M. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem. 41, 5020-5036.
20. Collins, J. L., Blanchard, S. G., Boswell, E. G., Charifson, P. S., Cobb, J. E., Henke, B. R., Hull-Ryde, E. A., Kazmierski, W. M., Lake, D. H., Leesnitzer, L. M., Lehmann, J., Lenhard, J. M., Orband-Miller, L. A., Gray-Nunez, Y., Parks, D. J., Plunkett, K. D., and Tong, W. Q. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 2. Structure-activity relationship and opitimization of the phenyl alkyl ether moiety. J. Med. Chem. 41, 5037-5054.
21. Cobb, J. E., Blanchard, S. G., Boswell, E. G., Brown, K. K., Charifson, P. S., Cooper, J. P., Collins, J. L., Dezube, M., Henke, B. R., Hull-Ryde, E. A., Lake, D. H., Lenhard, J. M., Oliver, W., Jr., Oplinger, J., Pentti, M., Parks, D. J., Plunket, K. D., and Tong, W. Q. (1998) N-(2-Benzoylphenyl)- L-tyrosine PPARγ agonists. 3. Structure-activity relationship and opitimization of the N-aryl substituent. J. Med. Chem. 41, 5055-5069.
22. Willson, T. M., Brown, P. J., Sternbach, D. D., and Henke, B. R. (2000) The PPARs: From orphan receptors to drug discovery. J. Med. Chem 43, 527-550.
23. Haigh, D., Allen, G., Birrell, H. C., Buckle, D. R., Cantello, B. C., Eggleston, D. S., Haltiwanger, R. C., Holder, J. C., Lister, C. A., Pinto, I. L., Rami, H. K.;, Sime, J. T., Smith, S. A., and Sweeney, J. D. (1999) Nonthiazolidinedione antihyperglycaemic agents. Part 3: The effects of stereochemistry on the potency of alpha-methoxy-beta-phenylpropanoic acids. Bioorg. Med. Chem. 7, 821-830.
24. Young, P. W., Buckle, D. R., Cantello, B. C., Chapman, H., Clapham, J. C., Coyle, P. J., Haigh, D., Hindley, R. M., Holder, J. C., Kallender, H., Latter, A. J., Lawrie, K. W., Mossakowska, D., Murphy, G. J., Roxbee, C. L., and Smith, S. A. (1998) Identification of high-affinity binding sites for the insulin sensitizer resiflitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. J. Pharmacol. Exp. Ther. 284, 751-759.
25. Katzenellenbogen, J. A., Heiman, D. F., Carlson, K. E., and Lloyd, J. E. (1982) In vivo and in vitro steroid receptor assays in the design of estrogen pharmaceuticals. In Receptor Binding Radiotracers (Eckelman, W. C., Ed.), Vol. 1, Chapter 6, pp 93-126, CRC Press, Boca Raton.
26. Koser, G. F., Wettach, R. H., and Smith, C. S. (1980) New methodology in iodonium salt synthesis. Reaction of [hydoxy-(tosyloxy)iodo]arenas with aryltrimethylsilanes. J. Org. Chem. 45, 1542-1543.
27. van der Puy, M. (1982) Conversion of diaryliodonium salts to aryl fluorides. J. Fluorine Chem. 21, 385-392.
28. 18F]-fluoride ion with diaryliodonium salts. J. Chem. Soc., Perkin Trans. 1, 2043-2046.
29. Pike, V. W., Butt, F., Shah, A., and Widdowson, D. A. (1999) Facile synthesis of substituted diaryliodonium tosylates by treatment of aryltributylstannanes with Koser's reagent. J. Chem. Soc., Perkin Trans, 1, 245-248.
30. Pangborn, A. B., Giardello, M. A., Grubbs, R. H., Rosen, R. K., and Timmer, F. J. (1996) Safe and convenient procedure for solvent purification. Organometallics 15, 1518-1520.
31. Kazmierczak, P., Skulski, L., and Kraszkiewicz, L. (2001) Synthesis of (diacetoxyiodo)arenas of iodylarenes from iodoarenes, with sodium periodate as the oxidant. Molecules 9, 881-891.
32. Togo, H., Nabana, T., and Yamaguchi, K. (2000) Preparation and reactivities of novel (diacetoxyiodo)arenas bearing heteroaromatics. J. Org. Chem. 65, 8391-8394.
33. Nabana, T., and Togo, H. (2002) Reactivities of novel [hydoxy-(tosyloxy)iodo]arenas and [hydoxy(phosphoryloxy)iodo]arenas for α-tosyloxylation and α-phosphoryloxylation of ketones. J. Org. Chem 67, 4362-4365.
34. Sun, S., Almaden, J., Carlson, T. J., Barker, J., and Gehring, M. R. (2005) Assay development and data analysis of receptor-ligand binding based on scintillation proximity assay. Metab. Eng. 7, 38-44.
35. Xu, H. E., Lambert, M. H., Montana, V. G., Plunket, K. D., Moore, L. B., Collins, J. L., Oplinger, J. A., Kliewer, S. A., Gampe, R. T., Jr., McKee, D. D., Moore, J. T., and Willson, T. M. (2001) Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 13919-13924.
36. Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., Novak, P. J., Faison, W., Binz, J. G., Hashim, M. A., Oliver, W. O., Brown, H. R., Parks, D. J., Plunket, K. D., Tong, W. Q., Menius, J. A., Adkison, K., Noble, S. A., and Wilson, T. M. (1999) A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 48, 1415-1424.
37. 18F-radiofluorinations of aromatic molecules. Appl. Radiat. Isot. 44, 889-893.
38. 18F]fluorophenol. Nucl. Med. Biol. 29, 255-262.
39. 18F]GBR-13119. J. Labelled Compd. Radiopharm. 27, 823-833.
40. Grushin, V. V. (1992) Carboranylhalonium ions: From striking reactivity to a unified mechanistic analysis of polar reactions of diarylhalonium compounds. Acc. Chem. Res. 25, 529-536.
41. Grushin, V. V., Demkina, I. I., and Tolstaya, T. P. (1992) Unified mechanistic analysis of polar reactions of diaryliodonium salts. J. Chem. Soc., Perkin Trans. 2, 505-511.
42. Papoutsis, I., Spyroudis, S., Varvoglis, A., and Raptopoulou, C. P. (1997) Arylidonium derivatives of 2-amino-1,4-quinones: Preparation and reactivity. Tetrahedron 53, 6097-6112.